chinese journal of experimental traditional medical formulae

Chinese Journal of Experimental Traditional Medical formulae

Chinese Journal of Experimental Traditional Medical formulae (E ISSN: 2097-1494)   The journal publishes research reports in the form of original articles or short communications on most aspects of pharmaceutical sciences, with strong emphasis on originality and scientific quality. More specifically, but not exclusively, the journal publishes mainly reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery, pharmaceutical technology and biotechnology, pharmaceutical care, and clinical drug evaluation, patient care, research, and education in primary care, general internal medicine, and hospital medicine. Its articles focus on topics such as clinical medicine, epidemiology, prevention, health care delivery, curriculum development, and numerous other non-traditional themes, in addition to classic clinical research on problems in internal medicine. Reviews or mini-reviews are not encouraged, but experimental articles are privileged. Articles reporting the isolation of secondary metabolites of plants will be only considered if biological and toxicological assays are included. In general, reports on biological activities of crude extracts are not considered for publication unless any bioactive compound is isolated and identified. Contributions reporting unexceptional and predictable bioactivity (for instance, antioxidant activity of extracts or antimicrobial activity of essential oils) are not normally considered for publication.

• Editor in Chief: Windall S. Chinua
• E-ISSN : 1005-9903 E-ISSN:2097-1494
• Frequency: Three times a year

Abstracting and Indexing Information

• Abstracts on Hygiene & Communicable Diseases (CABI)
• Academic OneFile (GALE Cengage)
• Academic Search Alumni Edition (EBSCO Publishing)
• Academic Search Complete (EBSCO Publishing)
• Academic Search Elite (EBSCO Publishing)
• Academic Search Premier (EBSCO Publishing)
• Academic Search Ultimate (EBSCO Publishing)
• Agricultural Economics Database (CABI)
• Biological Abstracts (Clarivate Analytics)
• Biomedical Reference Collection (EBSCO Publishing)
• BIOSIS Previews (Clarivate Analytics)
• CAB Abstracts® (CABI)
• CINAHL: Cumulative Index to Nursing & Allied Health Literature (EBSCO Publishing)
• Consumer Health Complete (EBSCO Publishing)
• Current Contents: Clinical Medicine (Clarivate Analytics)
• Current Contents: Life Sciences (Clarivate Analytics)
• Dairy Science Abstracts (CABI)
• Embase (Elsevier)
• Environmental Impact (CABI)
• Global Health (CABI)
• Health Reference Center Academic (GALE Cengage)
• Health Source Nursing/Academic (EBSCO Publishing)
• HEED: Health Economic Evaluations Database (Wiley-Blackwell)
• IDIS: Iowa Drug Information Service (University of Iowa)
• Leisure Tourism Database (CABI)
• MEDLINE/PubMed (NLM)
• Nursing Resource Center (GALE Cengage)
• Nutrition & Food Sciences Database (CABI)
• Nutrition Abstracts & Reviews Series A: Human & Experimental (CABI)
• Parasitology Database (CABI)
• Protozoological Abstracts (CABI)
• Review of Medical & Veterinary Entomology (CABI)
• Science Citation Index (Clarivate Analytics)
• Science Citation Index Expanded (Clarivate Analytics)
• SCOPUS (Elsevier)
• Soybean Abstracts Online (CABI)
• STM Source (EBSCO Publishing)
• Tropical Diseases Bulletin (CABI)
• Veterinary Science Database (CABI)
• VetMed Resource (CABI)
• Ei Compendex 

Current Issue

Vol. 24, No. 2(2024)

Published: 2024-10-10

Sexuality & Intimacy: A study of health-related Standard of life Post Covid-19 era

Reducing heavy metal (zn, cu) toxicity in a semi-arid area by halophytes, theoretical finding through molecular dynamics of novel piperazine sulfonyl amine based nmda-nr2b receptor antagonist, discussion on modern progress and research methods of human chromosome high resolution, perseverance ring chromosome 15 case report, hereditary hemorrhagic telangiectasia complicated with pulmonary hemangioma and left arteriovenous, the study of coronary stenting, the future of supply chain: innovations, best practices, and key trends, vol. 24 no. 1 (2024), vol. 23 no. 1 (2023), vol. 22 no. 1 (2022), vol. 21 no. 1 (2021), vol. 20 no. 1 (2020), vol. 19 no. 1 (2019).

Submission and review

• Journal Author Center
• LATEST ISSUE
• COVER STORIES
• ARTICLE COLLECTION

Advanced Search

• Acta Mathematica Scientia (Series B)
• Acta Analysis Functionalis Applicata
• Acta Ecologica Sinica
• Animal Nutrition
• Advances in Psychological Science
• Academic Journal of Chinese PLA Medical School
• ACTA GEOLOGICA SINICA
• Asian Journal of Sport and Exercise Psychology
• Advances in New and Renewable Energy
• Chemistry 化学
• Computer Science 计算机科学
• Earth and Planetary Sciences 地球与行星科学
• Engineering 工程
• Materials Science 材料科学
• Mathematics 数学
• Physics and Astronomy 物理学和天文学
• Agricultural and Biological Sciences 农业和生物科学
• Biochemistry, Genetics and Molecular Biology 生物化学、遗传学和分子生物学
• Medicine and Dentistry 医学和牙科
• Physical Sciences and Engineering
• Life Sciences
• Health Sciences
• Social Sciences and Humanities
• Submission and Review
• Open access
• Author Guidelines
• Terms and conditions
• Privacy policys
• Cookie Notice
• {{lang == 'en_US' ? 'Site Map' : '网站地图'}}
• Potentially offensive content
• Open Access

Release Rime *

Outer chain, choose file ( the image size equal or less than 1mb ).

Selection issue

{{addoredit}}.

选择图片（图片大小1MB）

• About the Journal
• Browse Articles
• International Clinical Practice Guideline of Traditional Chinese Medicine ‧ Viral Myocarditis
• Research on Guidance of Prevention and Treatment of Vascular Diseases by Yingwei Theory of Vessel-collateral Theory
• Traditional Chinese Medicine Treatment Guidelines on Coronary Heart Disease Before and After Percutaneous Coronary Intervention
• Prescription Law of New Coronavirus Pneumonia in Different Stages
• Efficacy Evaluation of Jinchai Kangbingdu Capsule Based on Coronaryvirus Pneumonia with 'Hanshi Yidu Xifei' syndrome Model
• Psychological Adjustment During Outbreak of COVID-19 Based on Traditional Chinese Medicine Emotion Therapy
• Reviewer Login
• Editor Login
• Author Login
• Current Issue
• Online First
• Most Downloaded

Periodical information

External links.

Postcode：100700

Phone：010-84076882

E-mail：[email protected]

Mobile website

® 2024 All Rights Reserved

Supported by:Beijing E-Tiller Technology Development Co., Ltd.

• Personal Center

Chinese Journal of Experimental Traditional Medical Formulae  (ISSN 1005-9903; CN 11-3495/R) is a professional academic journal supervised by the National Administration of Traditional Chinese Medicine, and co-sponsored by the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences and China Association of Chinese Medicine. The journal serves readers who are engaged in medicine, especially senior and intermediate researchers and workers in prescription teaching, scientific research, medical treatment, and production, as well as senior students of traditional Chinese medicine colleges and universities. The journal is semi-monthly and published on the 5th and 20th of each month in China and abroad. The author is requested to read the  article agreement carefully before submitting the article, and any subsequent submission will be regarded as recognition of the principles described below.

  1. Columns

The regular columns of Chinese Journal of Experimental Traditional Medical Formulae include monograph, classic prescriptions, compatibility, pharmacology, toxicology, clinic, drug metabolism, pharmaceutical preparation and processing, resource and quality evaluation, data mining, review, and related topics. Please read our published issues to understand the scope and format of the articles in each column.

  2. Submission matters

1) The author should submit the article online on our website, and the manuscript is written in Word file format. The author is required to select the column according to the major of the paper and upload the manuscript. The  manuscript  is not allowed to send to any individuals (including the editor-in-chief). The project involved in the article should be footnoted at the bottom left of the title page, and the introduction letter of the unit and the first page scan of the fund project assignment related to the content should be uploaded. The journal does not cooperate with any organization in soliciting manuscripts, and any act claiming to cooperate with our journal in soliciting manuscripts is an infringement. The journal will  protect legitimate rights and interests through legal channels.  

2)  Multiple submissions or repeated publication of the same manuscript are rejected. The submission should indicate whether the article has been published in non-public journals or communicated at academic conferences. If it has been published in another language, the  author is demanded to provide a written document with the consent of the first publication.  

3) The submitted manuscript should be an academic article written by the author based on the latest academic research results. The content of the manuscript should be scientific, innovative, and practical, with accurate data, clear arguments, concise text, clear hierarchy, and correct statistical processing. The content of the manuscript shall be   authentic, without data forgery and false information, and shall not involve plagiarism and other acts of infringement of others’ intellectual property rights. Meanwhile, it is recommended to upload the   introduction letter of the unit and the first page scan of fund project assignment in the form of attachment.  

4) According to the  Copyright Law of the People’s Republic of China and the situation of the journal,  manuscripts submitted to the journal without receiving the notification of processing within one month  are considered as under review. If the author wants to submit to another journal, please contact us first to ensure that the article has been withdrawn from the submission system, thereby avoiding multiple submissions. Meanwhile, the editorial department may modify or abridge the  text of the manuscript, and any modification involving the  original intention will be referred to the author for consideration. If the manuscript is not revised three months after the deadline, it will be regarded as automatic retraction. The   priority publication period of this journal online is generally 5–90 days. After the priority publication, the title, author’s name and order, and author’s unit are not allowed to be modified. Other text, data, charts, and references can still be modified appropriately.  

5) Manuscripts are free of manuscript processing fees. After the manuscript is confirmed to print, the page fee shall be paid  in line with the amount of notice, and color prints will be charged  additionally. After the manuscript is published, remuneration will be paid (including remuneration for  CD and online edition), and two copies of the current issue will be given as a gift.

3. About the  author

The author refers to the person (including natural person, legal person, or organization) who has made substantial contribution to the article. In principle, the order of the author’s signature is determined by the contribution, which shall be agreed by all authors before submission, and shall not be modified after submission. To request such a change, the author should explain the reasons to the editorial department, and submit written documents signed by all authors that they agree with the modification, with the official seal of the first unit or the unit where the corresponding author works. According to international practice, the first author of an article without a corresponding author is the corresponding author.

4. Retraction

If   any of the following acts are confirmed, the published articles will be retracted and retracted statements will be published in the online and print editions of the journal in accordance with relevant regulations and procedures: (1) academic misconduct such as plagiarism, data falsification and  tampering; (2) the reported academic research violating medical ethics; (3) repeated publication; (4) ethical problems in the process of manuscript review; (5) incredible findings and results reported in this article due to the intentional or unintentional errors of the author; (6) problems in violation of laws and regulations.

5. Transfer of copyright

Upon acceptance of an article, the author shall download the Copyright Transfer Agreement and author’s contribution description on the homepage of the journal, and these documents after being signed and sealed should be photographed and uploaded to the system.  The Chinese Journal of Experimental Traditional Medical Formulae   owns the exclusive right to publish the article in electronic journal , CD-edition, etc. No part of this article may be reproduced without the consent of the Chinese Journal of Experimental Traditional Medical Formulae.

Chinese Journal of Experimental Traditional Medical Formulae

Subject Area and Category

• Complementary and Alternative Medicine
• Medicine (miscellaneous)
• Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica

Publication type

10059903, 20971494

2019, 2021-2023

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

Evolution of the percentage of female authors.

Evolution of the number of documents cited by public policy documents according to Overton database.

Evolution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

Leave a comment

Name * Required

Email (will not be published) * Required

* Required Cancel

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Follow us on @ScimagoJR Scimago Lab , Copyright 2007-2024. Data Source: Scopus®

Cookie settings

Cookie Policy

Legal Notice

Privacy Policy

JournalTitle: Chinese Journal of Experimental Traditional Medical Formulae ISSN: 1005-9903

CityU Scholars A Research Hub of Excellence

System upgrade will be carried out on 12 Dec 2024 (THU) from 8:00 pm to 9:00 pm (HK Time) . The system will not be available during this period.

• Researchers
• Research Units

Research Output

• Prizes/Honours
• Student Theses
• Press/Media

Chinese Journal of Experimental Traditional Medical Formulae

ISSNs: 1005-9903

Additional searchable ISSN (electronic): 2097-1494

China Academy of Chinese Medical Sciences Institute of Chinese Materia Medica

Scopus rating (2023): CiteScore 0.7 SJR 0.138 SNIP 0.202

• Publication date
• Type and year
• Year, type and title
• Total citations (Scopus)

Identifiers

Linking ISSN (ISSN-L): 1005-9903

Google https://www.google.com/search?q=ISSN+%221005-9903%22

Bing https://www.bing.com/search?q=ISSN+%221005-9903%22

Yahoo https://search.yahoo.com/search?p=ISSN%20%221005-9903%22

Resource information

Title proper: Zhongguo shiyan fangjixue zazhi.

Parallel title: Chinese Journal of Experimental Traditional Medical Formulae

Country: China

Medium: Print

Record information

Last modification date: 27/04/2024

Type of record: Confirmed

ISSN Center responsible of the record: ISSN National Centre for China For all potential issues concerning this bibliographic record (missing or wrong data etc.), please contact the ISSN National Centre mentioned above by clicking on the link.

downloads requested

Discover all the features of the complete ISSN records

Display mode x.

Labelled view

MARC21 view

UNIMARC view